盘前跳水6%!诺和诺德CEO突然辞职,承认面临激烈市场挑战

华尔街见闻
16 May

盘周五,诺和诺德宣布,由于担忧公司正在失去其在竞争激烈的肥胖药物市场中的先发优势,CEO Lars Fruergaard Jorgensen将辞职。诺和诺德在一份声明中表示: "鉴于诺和诺德最近面临的市场挑战,以及自2024年年中以来公司股价的表现,公司做出了这一变更。" 在Jorgensen的领导下,诺和诺德凭借其减重药物Wegovy和Ozempic的销量飙升,成为世界肥胖药物市场的领导者,...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10